{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:04:11Z","timestamp":1780589051362,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.acuroe.2026.501897","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T16:52:17Z","timestamp":1767631937000},"page":"501897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Past and present of prostate cancer screening in the European Union"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0556-3035","authenticated-orcid":false,"given":"J.","family":"G\u00f3mez Rivas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"G\u00f3mez D\u00e1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Tarrazo Antelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Corujo Quinteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1.","family":"G\u00f3mez Amor\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rodr\u00edguez Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Vilaseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1.","family":"Borque-Fernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Moreno-Sierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Collen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Helleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Roobol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"van Poppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11\u201312","key":"10.1016\/j.acuroe.2026.501897_bib0005","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s004320050110","article-title":"A retrospective and prospective overview of prostate-specific antigen","volume":"123","author":"Ablin","year":"1997","journal-title":"J Cancer Res Clin Oncol."},{"issue":"5","key":"10.1016\/j.acuroe.2026.501897_bib0010","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.euo.2021.06.006","article-title":"A European model for an organised risk-stratified early detection programme for prostate cancer","volume":"4","author":"Van Poppel","year":"2021","journal-title":"Eur Urol Oncol [Internet]"},{"issue":"3","key":"10.1016\/j.acuroe.2026.501897_bib0015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.eururo.2020.12.010","article-title":"Early detection of prostate cancer in 2020 and beyond: facts and recommendations for the European union and the European commission","volume":"79","author":"Van Poppel","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2026.501897_bib0020","unstructured":"Early Detection of Prostate Cancer in the European Union: Combining Forces with PRAISE-U - PubMed [Internet]. [cited 2025 Mar 29]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37704541\/."},{"issue":"1","key":"10.1016\/j.acuroe.2026.501897_bib0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/ijc.11478","article-title":"Familial risk of cancer: data for clinical counseling and cancer genetics","volume":"108","author":"Hemminki","year":"2004","journal-title":"Int J Cancer."},{"issue":"17","key":"10.1016\/j.acuroe.2026.501897_bib0030","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/jnci\/djq265","article-title":"Effects of prostate-specific antigen testing on familial prostate cancer risk estimates","volume":"102","author":"Bratt","year":"2010","journal-title":"J Natl Cancer Inst."},{"issue":"15","key":"10.1016\/j.acuroe.2026.501897_bib0035","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","article-title":"10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer","volume":"375","author":"Hamdy","year":"2016","journal-title":"New England Journal of Medicine [Internet]"},{"key":"10.1016\/j.acuroe.2026.501897_bib0040","unstructured":"Terapia de privaci\u00f3n de andr\u00f3genos en el c\u00e1ncer de pr\u00f3stata localizado. Situaci\u00f3n actual y tendencias futuras | Actas Urol\u00f3gicas Espa\u00f1olas [Internet]. [cited 2022 Oct 23]. Available from: https:\/\/www.elsevier.es\/es-revista-actas-urologicas-espanolas-292-avance-resumen-terapia-privacion-androgenos-el-cancer-S021048062200105X."},{"key":"10.1016\/j.acuroe.2026.501897_bib0045","first-page":"543","article-title":"Management of erectile disfunction following robot-assisted radical prostatectomy: a systematic review","volume":"72","author":"Marchioni","year":"2020","journal-title":"Minerva Urol Nefrol."},{"issue":"1","key":"10.1016\/j.acuroe.2026.501897_bib0050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1470-2045(00)00103-0","article-title":"PSA assays","volume":"1","author":"Ablin","year":"2000","journal-title":"Lancet Oncol [Internet]"},{"issue":"5","key":"10.1016\/j.acuroe.2026.501897_bib0055","first-page":"406","article-title":"Prostate cancer: to screen or not to screen","volume":"64","author":"Bailey","year":"2011","journal-title":"Arch Esp Urol."},{"issue":"1","key":"10.1016\/j.acuroe.2026.501897_bib0060","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.eururo.2010.03.033","article-title":"ERSPC and PLCO prostate cancer screening studies: what are the differences?","volume":"58","author":"Schr\u00f6der","year":"2010","journal-title":"Eur Urol."},{"issue":"3","key":"10.1016\/j.acuroe.2026.501897_bib0065","first-page":"127","article-title":"Screening for prostate cancer: a review of the ERSPC and PLCO trials","volume":"11","author":"Eckersberger","year":"2009","journal-title":"Rev Urol [Internet]"},{"issue":"8","key":"10.1016\/j.acuroe.2026.501897_bib0070","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S1470-2045(10)70146-7","article-title":"Mortality results from the G\u00f6teborg randomised population-based prostate-cancer screening trial","volume":"11","author":"Hugosson","year":"2010","journal-title":"Lancet Oncol [Internet]"},{"issue":"2","key":"10.1016\/j.acuroe.2026.501897_bib0075","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/JU.0000000000002696","article-title":"Results from 22 years of Followup in the G\u00f6teborg Randomized Population-Based Prostate Cancer Screening Trial","volume":"208","author":"Fr\u00e5nlund","year":"2022","journal-title":"J Urol [Internet]"},{"issue":"4","key":"10.1016\/j.acuroe.2026.501897_bib0080","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/cncr.30472","article-title":"Insights from the PLCO trial about prostate cancer screening","volume":"123","author":"Gulati","year":"2017","journal-title":"Cancer."},{"issue":"1","key":"10.1016\/j.acuroe.2026.501897_bib0085","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.eururo.2016.01.009","article-title":"Lethal prostate cancer in the PLCO cancer screening trial","volume":"70","author":"Shoag","year":"2016","journal-title":"Eur Urol."},{"key":"10.1016\/j.acuroe.2026.501897_bib0090","article-title":"From screening to mortality reduction: an overview of empirical data on the patient journey in European randomized study of screening for prostate cancer Rotterdam after 21 years of follow-up and a reflection on quality of life","author":"Hogenhout","year":"2023","journal-title":"Eur Urol Oncol [Internet]"},{"issue":"7","key":"10.1016\/j.acuroe.2026.501897_bib0095","doi-asserted-by":"crossref","first-page":"449","DOI":"10.7326\/M16-2586","article-title":"Reconciling the effects of screening on prostate cancer mortality in the ERSPC and PLCO trials","volume":"167","author":"Tsodikov","year":"2017","journal-title":"Ann Intern Med."},{"issue":"1","key":"10.1016\/j.acuroe.2026.501897_bib0100","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.euo.2021.09.001","article-title":"Prostate cancer screening with magnetic resonance imaging: results from the second round of the G\u00f6teborg prostate cancer screening 2 trial","volume":"5","author":"Wallstr\u00f6m","year":"2022","journal-title":"Eur Urol Oncol."},{"key":"10.1016\/j.acuroe.2026.501897_bib0105","unstructured":"Prostate Cancer - Uroweb [Internet]. [cited 2025 Mar 29]. Available from: https:\/\/uroweb.org\/guidelines\/prostate-cancer."},{"key":"10.1016\/j.acuroe.2026.501897_bib0110","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.euf.2018.02.012","article-title":"Prostate indeterminate lesions on magnetic resonance imaging\u2014biopsy versus surveillance: a literature review [Internet]","volume":"5","author":"G\u00f3mez Rivas","year":"2019","journal-title":"European Urology Focus"},{"issue":"2","key":"10.1016\/j.acuroe.2026.501897_bib0115","first-page":"105","article-title":"Biomarkers in prostate cancer management. Is there something new?","volume":"72","author":"Carrion","year":"2019","journal-title":"Arch Esp Urol [Internet]"},{"issue":"3","key":"10.1016\/j.acuroe.2026.501897_bib0120","article-title":"Prostate cancer risk calculators for healthy populations: systematic review","volume":"7","author":"Bandala-Jacques","year":"2021","journal-title":"JMIR Cancer [Internet]"},{"issue":"13","key":"10.1016\/j.acuroe.2026.501897_bib0125","article-title":"Comparing two targeted biopsy schemes for detecting clinically significant prostate cancer in magnetic resonance index lesions: two- to four-core versus saturated transperineal targeted biopsy","volume":"16","author":"Morote","year":"2024","journal-title":"Cancers (Basel) [Internet]."},{"issue":"4","key":"10.1016\/j.acuroe.2026.501897_bib0130","doi-asserted-by":"crossref","first-page":"115.e1","DOI":"10.1016\/j.urolonc.2023.09.020","article-title":"Reducing the demand for magnetic resonance imaging scans and prostate biopsies during the early detection of clinically significant prostate cancer: applying the Barcelona risk-stratified pathway in Catalonia","volume":"42","author":"Morote","year":"2024","journal-title":"Urol Oncol [Internet]"},{"issue":"1","key":"10.1016\/j.acuroe.2026.501897_bib0135","article-title":"Integrating radiological and clinical data for clinically significant prostate cancer detection with machine learning techniques","volume":"15","author":"Esteban","year":"2025","journal-title":"Sci Rep [Internet]"},{"issue":"6","key":"10.1016\/j.acuroe.2026.501897_bib0140","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.eururo.2020.02.009","article-title":"Radical prostatectomy or observation for clinically localized prostate cancer: extended follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT)","volume":"77","author":"Wilt","year":"2020","journal-title":"Eur Urol [Internet]"},{"issue":"1","key":"10.1016\/j.acuroe.2026.501897_bib0145","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.eururo.2017.01.033","article-title":"Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth","volume":"72","author":"Roobol","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2026.501897_bib0150","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.eururo.2018.07.031","article-title":"Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators","volume":"75","author":"Alberts","year":"2019","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.acuroe.2026.501897_bib0155","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.eururo.2021.07.024","article-title":"Prostate-specific antigen testing as part of a risk-adapted early detection strategy for prostate cancer: European association of urology position and recommendations for 2021","volume":"80","author":"Van Poppel","year":"2021","journal-title":"Eur Urol [Internet]"},{"issue":"7","key":"10.1016\/j.acuroe.2026.501897_bib0160","article-title":"Understanding The Barriers to Prostate Cancer Population-Based Early Detection Programs: The PRAISE-U BEST Survey","volume":"14","author":"Beyer","year":"2024","journal-title":"J Pers Med [Internet]"},{"issue":"6","key":"10.1016\/j.acuroe.2026.501897_bib0165","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.eururo.2023.08.002","article-title":"Early detection of prostate cancer in the European union: combining forces with PRAISE-U","volume":"84","author":"Van Poppel","year":"2023","journal-title":"Eur Urol [Internet]."}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578626000089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578626000089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:49:34Z","timestamp":1780588174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173578626000089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2173578626000089"],"URL":"https:\/\/doi.org\/10.1016\/j.acuroe.2026.501897","relation":{},"ISSN":["2173-5786"],"issn-type":[{"value":"2173-5786","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Past and present of prostate cancer screening in the European Union","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuroe.2026.501897","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2025.501897","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"501897"}}